During the past decade, Hamburgisches Forschungsinstitut fuer CED conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hamburgisches Forschungsinstitut fuer CED" #1 sponsor was "Eli Lilly and Company" with 3 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "Florian Beigel" with 1 trials sponsored, "Neovacs" with 1 trials sponsored and "VHsquared Ltd." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

According to Clinical.Site data, the most researched conditions in "Hamburgisches Forschungsinstitut fuer CED" are "Ulcerative Colitis" (4 trials), "Crohn's Disease" (3 trials), "Bile Acid Malabsorption" (1 trials) and "Crohns Disease" (1 trials). Many other conditions were trialed in "Hamburgisches Forschungsinstitut fuer CED" in a lesser frequency.

Most popular intervention types in "Hamburgisches Forschungsinstitut fuer CED" are "Drug" (7 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Mirikizumab" (2 trials), "Colesevelam" (1 trials), "Etrolizumab" (1 trials) and "Etrozulimab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hamburgisches Forschungsinstitut fuer CED" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Hamburgisches Forschungsinstitut fuer CED". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Hamburgisches Forschungsinstitut fuer CED, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hamburgisches Forschungsinstitut fuer CED, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".